483 Antares Pharma Jan 2016

483 Antares Pharma Jan 2016

Susan Matthias FDA$119.00 - Available Now

FDA investigators audited the Antares Pharma - Minneapolis, MN, United States facility and issued inspectional observations (via FDA 483) on 21 Jan 2016.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 21 Jan 2016
  • Location: Minneapolis, United States
  • FEI: 2182861
Add To Cart